Stemtech (STEK) EBT (2012 - 2025)

Stemtech has disclosed EBT across 14 years of filings, most recently posting -$1.5 million for Q4 2025.

• EBT for Q4 2025 came in at -$1.5 million, down 273.77% year-over-year; the trailing twelve-month figure through Dec 2025 was -$4.0 million (down 7.35% YoY), and the FY2025 annual result was -$4.0 million, down 7.35% from the prior year.
• EBT came in at -$1.5 million for Q4 2025 at Stemtech, down from -$812541.0 in the prior quarter.
• In the past five years, EBT ranged from a high of $17.4 million in Q3 2022 to a low of -$25.0 million in Q2 2022.
• The 5-year median for EBT is -$830348.0 (2021), against an average of -$1.4 million.
• Peak annual rise in EBT reached 426.83% in 2022, while the deepest fall reached 3129.07% in 2022.
• Stemtech's EBT stood at -$848155.0 in 2021, then surged by 47.4% to -$446114.0 in 2022, then slumped by 317.83% to -$1.9 million in 2023, then soared by 78.72% to -$396580.0 in 2024, then plunged by 273.77% to -$1.5 million in 2025.
• The last three EBT figures came in at -$1.5 million (Q4 2025), -$812541.0 (Q3 2025), and -$296280.0 (Q2 2025), per Business Quant data.